Rapid Growth Enzymedica operates in the wellness and digestive health space with a revenue range of 50-100 million and a strong market position as a leader in enzyme therapies, presenting OTB opportunities to expand distribution and retail partnerships in natural channels and mainstream health retailers.

Product Franchise A core portfolio featuring Digest Gold and Digest blends, Thera-blend enzyme technology, vegan/kosher options, and carbon-neutral operations offers cross-sell potential into digestive health, immune support, and cardiovascular wellness segments across retailers and B2B channels.

Channel Expansion Recent activity includes functional foods and cookie products (Fiber+ Cookies) and COOs appointed for operations, signaling a push into CPG and direct-to-consumer opportunities that can be leveraged to broaden shelf presence and D2C campaigns with retailers and e-commerce platforms.

Strategic Partnerships Partnerships with social, advertising, and e-commerce tech stacks (Shopify, Attentive, Amazon Advertising, TikTok Shop) indicate readiness for programmatic promotions, influencer collaborations, and personalized marketing to drive trial and repeat purchases.

Quality & Trust NSF certification, no fillers, plant-based enzymes, and carbon-neutral certification support premium positioning and can be leveraged to target retailers seeking high-quality, sustainable, and transparent brands with strong provable health claims.